<code id='76AB8BBBBA'></code><style id='76AB8BBBBA'></style>
    • <acronym id='76AB8BBBBA'></acronym>
      <center id='76AB8BBBBA'><center id='76AB8BBBBA'><tfoot id='76AB8BBBBA'></tfoot></center><abbr id='76AB8BBBBA'><dir id='76AB8BBBBA'><tfoot id='76AB8BBBBA'></tfoot><noframes id='76AB8BBBBA'>

    • <optgroup id='76AB8BBBBA'><strike id='76AB8BBBBA'><sup id='76AB8BBBBA'></sup></strike><code id='76AB8BBBBA'></code></optgroup>
        1. <b id='76AB8BBBBA'><label id='76AB8BBBBA'><select id='76AB8BBBBA'><dt id='76AB8BBBBA'><span id='76AB8BBBBA'></span></dt></select></label></b><u id='76AB8BBBBA'></u>
          <i id='76AB8BBBBA'><strike id='76AB8BBBBA'><tt id='76AB8BBBBA'><pre id='76AB8BBBBA'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:51616
          CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

          WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

          Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

          advertisement

          Pharmaceutical groups and patient advocates are increasingly fighting that approach.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          Biotech incubator Curie.Bio graduates its first startup
          Biotech incubator Curie.Bio graduates its first startup

          ChristophLengauer,co-founderandCSOofCurie.BioVanessaLeroyforSTATCurie.Bio,thenewbiotechinvestmentfir

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Black vets could get higher VA benefits if race not used in lung test

          AdobeRemovingapatient’sracefromanequationusedtoassesslungfunction—achangecalledforbyhealthequityadvo